248 related articles for article (PubMed ID: 12679308)
1. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
Simmons R; Thevarajah S; Brennan MB; Christos P; Osborne M
Ann Surg Oncol; 2003 Apr; 10(3):242-7. PubMed ID: 12679308
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
3. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
4. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
Simmons RM; Smith SM; Osborne MP
Breast J; 2001; 7(3):181-3. PubMed ID: 11469932
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
Thevarajah S; Huston TL; Simmons RM
Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
[TBL] [Abstract][Full Text] [Related]
8. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
Nour A
Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
[TBL] [Abstract][Full Text] [Related]
10. Optimization of sentinel lymph node identification techniques in the Indian setting: A randomized clinical trial.
Seenu V; Suhani S; Srivastava A; Parshad R; Mathur S; Kumar R
Indian J Cancer; 2019; 56(2):114-118. PubMed ID: 31062728
[TBL] [Abstract][Full Text] [Related]
11. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
12. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
Knackstedt RW; Knackstedt T; Gastman B
J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
[TBL] [Abstract][Full Text] [Related]
15. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
[TBL] [Abstract][Full Text] [Related]
16. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
18. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.
Derossis AM; Fey J; Yeung H; Yeh SD; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
J Am Coll Surg; 2001 Nov; 193(5):473-8. PubMed ID: 11708502
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
[TBL] [Abstract][Full Text] [Related]
20. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
Chung A; Yu J; Stempel M; Patil S; Cody H; Montgomery L
Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
